Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the efficacy of PSI-7977 in combination with RBV administered for 12 weeks compared with PEG/RBV administered for 24 weeks in treatment-naïve patients with HCV genotype 2 or 3 as assessed by the rate of SVR12 (HCV RNA <LOQ 12 weeks after cessation of therapy)
Critère d'inclusion
- Chronic Genotype 2 or 3 HCV Infection